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Hyperbaric oxygen attenuates neuropathic
pain and reverses inflammatory signaling
likely via the Kindlin-1/Wnt-10a signaling
pathway in the chronic pain injury model
in rats
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Abstract
Background: Hyperbaric oxygen (HBO) therapy is proven to attenuate neuropathic pain in rodents. The goal of the
present study was to determine the potential involvement of the Kindlin-1/Wnt-10a signaling pathway during
astrocyte activation and inflammation in a rodent model of neuropathic pain.
Methods: Rats were assigned into sham operation, chronic constriction injury (CCI), and CCI + HBO treatment
groups. Neuropathic pain developed in rats following CCI of the sciatic nerve. Rats in the CCI + HBO group received
HBO treatment for five consecutive days beginning on postoperative day 1. The mechanical withdrawal threshold
(MWT) and the thermal withdrawal latency (TWL) tests were performed to determine mechanical and heat
hypersensitivity of animals, respectively. Kindlin-1, Wnt-10a and β-catenin protein expression was examined by
immunohistochemistry and Western blot analysis. Expression of tumor necrosis factor (TNF)-α was also determined
by ELISA.
Results: Our findings demonstrated that HBO treatment significantly suppressed mechanical and thermal hypersensitivity
in the CCI neuropathic pain model in rats. HBO therapy significantly reversed the up-regulation of Kindlin-1 in dorsal root
ganglia (DRG), spinal cord, and hippocampus of CCI rats. CCI-induced astrocyte activation and increased levels of TNF-α
were efficiently reversed by HBO (P < 0.05 vs. CCI). HBO also reversed Wnt-10a up-regulation induced by CCI in the DRG,
spinal cord, and hippocampus (P < 0.05 vs. CCI).
Conclusions: Our findings demonstrate that HBO attenuated CCI-induced rat neuropathic pain and inflammatory
responses, possibly through regulation of the Kindlin-1/Wnt-10a signaling pathway.
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Background
Neuropathic pain, characterized by allodynia, spontaneous
pain, hyperalgesia, and paraesthesia, is among the most dif-
ficult types of chronic pain to clinically treat arising from
its complex etiology [1]. A large body of evidence has
shown that the quality of life for patients with neuropathic
pain is poor [2, 3]. Multiple concurrent mechanisms are
implicated in the processing of pain signals, and thus,
administration of combinations of drugs has been recom-
mended for the management of this debilitating type of
pain. However, clinical efficacy and side effects of using
combination pharmacotherapy remains unclear and vari-
able [4]. Hence, novel strategies targeting neuropathic pain
are much needed clinically. Indeed, non-pharmacological
approaches, such as transcutaneous electrical nerve stimu-
lation [5], transcranial magnetic stimulation [6], and electro
acupuncture [7] have been proven to significantly alleviate
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neuropathic pain. Nevertheless, the long-term efficacy of
these approaches is yet to be determined.
Hyperbaric oxygen (HBO) is a form of medical treatment
in which patients breath 100% oxygen under increased at-
mospheric pressure [8]. Emerging lines of evidence suggest
that HBO therapy can reduce chronic pain in animal
models [9–11]. In addition, the use of HBO treatment has
been proven to attenuate chronic cluster headaches and
[12] idiopathic trigeminal neuralgia in patients [13]. Our
previous study indicated that the antinociceptive effects of
HBO therapy may be linked to inhibition of astrocyte acti-
vation and inflammation in a chronic constriction injury
(CCI)-induced neuropathic pain model in rats [10]. How-
ever, the precise molecular mechanisms underpinning this
process are currently unknown.
Although the pathogenesis of neuropathic pain has not
yet been fully described, chronic inflammation caused by
astrocyte activation is believed to be one of the most cru-
cial events in the development of this condition [14]. The
activation of astrocytes in response to stimuli is driven by
β1 integrins [15]. Kindlin-1 is an integrin binding protein
which plays a key role in regulating integrin activity [16]. A
recent study demonstrated that Kindlin-1 controls cell pro-
liferation through regulation of the Wnt/β-catenin signal-
ing pathway [17]. Nevertheless, the potential involvement
of the Kindlin-1/Wnt signaling pathway in the observed
antinociceptive effects yielded by HBO treatment is still
unclear.
Here, we analyzed the neuropathic pain relieving effects
of HBO treatment by using a rodent CCI-induced pain
model. In addition, the potential activation of Kindlin-1/
Wnt signaling during astrocyte activation and inflammatory
responses upon neuropathic pain induction was deter-
mined. Our results showed that HBO therapy attenuated
neuropathic pain in rats, possibly through regulating
Kindlin-1/Wnt-10a signaling, astrocyte activation, and sub-
sequent inflammatory responses. These findings provide a
basic understanding of the molecular mechanism of neuro-
pathic pain pathogenesis, and suggest that HBO therapy
may be a promising non-pharmacological strategy for the
management of neuropathic pain.
Methods
Animals and experimental groups
Thirty-six 8–10 week-old male Sprague-Dawley (SD)
rats, weighing 250–280 g, were obtained from the
Guangdong Medical Laboratory Animal Center, Foshan,
Guangdong, China (Animal license No. SCXK 2013–
0002). The animals were housed individually in plastic
boxes at a controlled room temperature of 23–25 °C.
Animals had free access to water and food. Thirty-six
rats were randomly assigned into three groups with 12
animals per group, including sham operation control
group, CCI group, and CCI + HBO group. All efforts
were made to minimize suffering of the animals. The ani-
mal study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health,
and under approved protocols of the Institutional Animal
Ethics Committee of the Guangzhou Medical University
(2016–016).
Establishment of the chronic constriction injury (CCI)
neuropathic pain model in rats
CCI of the sciatic nerve was applied to induce neuro-
pathic pain in rats [10, 11]. In brief, animals were given
40 mg/kg body weight of sodium pentobarbital by intra-
peritoneal injection. Under anesthesia, the left sciatic
nerve of the rats in the CCI or the CCI + HBO group
was exposed at the mid-thigh level following blunt dis-
section of the left biceps femoris. Four ligatures were
then loosely tied around the exposed sciatic nerve at the
proximal area of the trifurcation at 1 mm intervals. After
induction of CCI, the wound was closed. An identical
dissection was carried out in animals from the sham op-
eration group, however, the sciatic nerve in these control
rats was not ligated.
Hyperbaric oxygen (HBO) treatment
A cylindrical HBO chamber (DS400-IV; Weifang Huaxin
Oxygen Industry Co., Ltd., Shandong, China) was utilized
for HBO treatment as described previously [10, 11].
Briefly, the chamber was filled with 100% oxygen continu-
ously before experiments. Animals in the CCI +HBO
group were then placed into the chamber. The pressure
within the chamber was increased at a rate of 0.1 ATA/
min to 2.0 ATA/min within 40 min, and was maintained
for one hour. At the end of the therapy, the pressure was
gradually decompressed to atmospheric pressure at a rate
of 0.1 ATA/min. Animals in the CCI +HBO group re-
ceived HBO treatment for five consecutive days starting
from postoperative day 1. Animals in the sham operation
control or CCI groups were allowed to stay in the cham-
ber for 100 min, but without any treatment.
Behavioral analysis
Behavioral tests were conducted on eight successive days
starting from the day prior to the operation. Rats were
habituated in a plexiglas chamber (Youer Equipment
Scientific Co., Ltd., Shanghai, China) for 1 h before
testing.
The mechanical withdrawal threshold (MWT) test was
performed to examine the paw response to mechanical
stimuli as previously described [11]. During the MWT
test, animals were placed in the chamber after habitu-
ation, and von Frey filaments (Stoelting Company,
Wood Dale, IL, USA) were used to stimulate the left
hind paw of each rat. The stimulation duration was
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approximately 3–5 s, with an interval of 30 s. A 0.6 g
von Frey force was directed on the plantar surface of the
hind paw following the up-and-down force stimulation
as described by Song et al. [18]. A positive response was
defined as an immediate withdrawal of the hind paw in
response to stimulation. A reduced force was generated
if the foot withdrawal occurred. In contrast, an increased
force was induced when a negative response occurred.
Such procedure was repeated until we identified the
least force that evoked withdrawal. The withdrawal
threshold was set as the von Frey force that induced
50% paw withdrawal. For each animal, the MWT test
was conducted ten times. A cut-off value of the von Frey
force was set at 15 g.
In order to examine paw sensitivity in response to
thermal stimulus, the thermal withdrawal latency (TWL)
assay was applied as reported previously [11]. Upon test-
ing, animals were placed on the surface of a glass plate
(3 mm thick) covered by a Plexiglas chamber with a
fully-automatic plantar analgesia tester (BME-410C)
obtained from Youer Equipment S cientific Co., Ltd.,
Shanghai, China. The left hind paw of the animal was
exposed to a heat stimulus. The duration of paw with-
drawal from the heat source was considered as TWL.
For each trial, five thermal stimuli at five min intervals
were delivered, and the average TWL was calculated. A
cut-off value of 30 s was set.
Sample preparation
After completing behavioral experiments 7 days post-
operatively, all rats were given 40 mg/kg sodium pento-
barbital intraperitoneally to induce anesthesia. Under
anesthesia, animals were transcardially perfused with
saline. Subsequently, the L5 dorsal root ganglion (DRG),
spinal cord areas between L4 and L6 segments as well as
the hippocampus were carefully removed and used for im-
munohistochemical analysis (four rats for each group).
Other tissues were used for Western blotting experiment
(four rats per group) and ELISA (four rats per group).
Immunohistochemical analysis
DRG, spinal cord, and hippocampal tissue sections
(5 μm thick) were incubated at 4 °C overnight with a
mouse anti-rat anti-Kindlin-1 (1:500 dilution, MAB2616;
Millipore, Billerica, MA, USA), rabbit anti-rat anti-Wnt-
10a (1:500 dilution, ab106522; Abcam, Cambridge, UK),
rabbit anti-rat anti-glial fibrillary acidic protein (GFAP)
(1:200 dilution, ab7260; Abcam, USA) antibody followed
by incubation with biotinylated secondary antibody
(1:200 dilution; Vector Laboratories, Burlingame, CA,
USA) in 1.5% normal donkey serum (NDS; Jackson
Immuno Research Laboratories Inc., West Grove, PA,
USA) for 20 min at 37 °C. Nuclei were stained with
DAPI (4′,6-diamidino-2-phenylindole). All sections were
examined under a confocal laser scanning microscope
(Leica SP2, Wetzlar, Germany). For each animal, DRG,
spinal cord and hippocampal sections (eight for each
sample) were randomly selected for data quantification.
The intensity of the optical density (OD) was calculated
using Image J analysis software (National Institutes of
Health, Bethesda, MD, USA) from eight sections for
each animal. For each section, five fields were randomly
selected under microscope. The percentage of GFAP-
positive astrocytes cells (activated astrocytes) was calculated
over the total number of cells. The average percentage of
activated astrocytes was calculated. Data quantification of
immunohistochemical analysis was carried out blindly with
respect to treatments.
Western blot analysis
Total protein was extracted from tissues using SDS lysis
buffer (P0013G; Beyotime, China) for evaluating the pro-
tein expressions of Kindlin-1, Wnt 10a, and β-catenin.
The concentration of extracted protein samples was
examined using the Pierce BCA assay. Equal amounts of
protein were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Clec-
trophoresis protein samples were then transferred to a
polyvinylidene fluoride membrane. After blocking in
phosphate buffer solution (PBS) containing 5% w/v non-
fat milk at 37 °C for 1–2 h, the membranes were incu-
bated with rabbit monoclonal anti-Kindlin-1 primary
antibody (1:1000 dilution; Millipore, USA), anti-Wnt-10a
antibody (1:500 dilution, Abcam, USA), or anti-β-
catenin antibody (1:1000 dilution, Abcam, USA) over-
night at 4 °C. Antibodies against β-actin were used as an
internal control. After washing with PBS-T (0.1%
Tween-20 in PBS) four times, membranes were treated
with horseradish peroxidase (HRP)-labeled secondary
antibodies (1:2000 dilution; Santa Cruz, Santa Cruz, CA,
USA) at 37 °C for 1 h. Immunolabeled protein bands were
visualized using an enhanced chemiluminescence (ECL)
assay (E-CS-0100c, Elabscience, Wuhan. China). The
bands of target proteins were analyzed using the Scion
Image software version 4.0.3 (Scion Corp., Frederick, MD,
USA). The densitometric values were used for statistical
analysis.
Determination of tumor necrosis factor (TNF)-α levels
The concentration of TNF-α in the hippocampus was mea-
sured by ELISA as described previous [19]. The unilateral
hippocampus, DRG, or spinal cord was dissected, ground
with a grinder, and loaded onto an ultrasonic tissue
homogenizer. The supernatant was collected after centrifu-
gation. TNF-α production was evaluated using ELISA kits
(Boster Biological Technology Co., Ltd., Wuhan, China).
OD values at 490 nm were recorded using a microplate
reader (NK3; Ladsystems, Helsinki, Finland). The average
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level of TNF-α was calculated based on a standard curve
provided by the kit.
Statistical analysis
Data were analyzed by the SPSS 17.0 software (SPSS
Inc., Chicago, IL, USA). Numerical data are presented as
the mean ± standard deviation. In order to compare the
differences among groups, one-way analysis of variance
(ANOVA), followed by the least significant difference
test, was applied. P < 0.05 was considered statistically
significant.
Results
HBO reduced mechanical and thermal hypersensitivity in
rodents with neuropathic pain
To induce neuropathic pain in rats, CCI of the sciatic
nerve was applied. MWT and TWL levels gradually de-
creased with time after surgery in animals of the CCI
group when compared with sham operation control rats
(Fig. 1). Development of significant mechanical hyper-
sensitivity was observed in CCI rats after postoperative
day 4 (P < 0.05 vs. sham) and heat hypersensitivity devel-
oped after postoperative day 2 (P < 0.05 vs. sham). These
data suggest the successful establishment of a neuro-
pathic pain model in rats.
HBO treatment greatly prevented the reduction in
MWT and TWL values induced by CCI (MWT, P < 0.05
vs. CCI after postoperative day 4; TWL, P < 0.05 vs. CCI
after postoperative day 2). These findings indicate that five
consecutive days of HBO treatment by suppressing mech-
anical and thermal hypersensitivity efficiently relieved
neuropathic pain in rats induced by CCI.
HBO reversed Kindlin-1 up-regulation induced by CCI
In order to clarify the molecular mechanisms involved in
HBO-mediated analgesia, the expression of Kindlin-1 in
the DRG, spinal cord, and hippocampal tissues was de-
termined using immunohistochemistry and Western blot
analysis on postoperative day 7. The expression of
Kindlin-1 was greatly up-regulated in the DRG, spinal
cord, and hippocampal tissues obtained from CCI rats
(Fig. 2, P < 0.05 vs. sham). However, HBO therapy sig-
nificantly reversed the up-regulation of Kindlin-1 levels
induced by CCI (Fig. 3, P < 0.05 vs. CCI), indicating that
Kindlin-1 may play a crucial role in HBO-mediated anal-
gesia in the rat neuropathic pain model.
HBO suppressed astrocyte activation and TNF-α generation
induced by CCI
We next determined the potential influence of HBO treat-
ment on astrocyte activation. For this purpose, tissue sam-
ples were stained with an anti-GFAP antibody which
specifically labels astrocytes. CCI induced the activation of
astrocytes in several tissues of the central nervous
system, including the DRG, spinal cord, and hippocam-
pus (Fig. 4a, b). HBO therapy significantly reduced
astrocyte activation. As astrocyte activation may lead to
inflammatory responses through the generation of pro-
inflammatory cytokines, such as TNF-α, the production of
TNF-α in the aforementioned neuronal tissues was deter-
mined using ELISA. As expected, CCI increased TNF-α
concentrations when compared with the sham operation
control group (P < 0.05 vs. sham) (Fig. 4c). However, HBO
treatment reduced the production of TNF-α following
CCI (P < 0.05 vs. CCI). These data indicate that HBO sup-
pressed astrocyte activation and subsequently prevented
astrocyte-induced inflammation.
Fig. 1 Mechanical and thermal hypersensitivity in rats. Animals in sham operation control (n = 12), CCI (n = 12), and CCI + HBO (n = 12) groups were
subjected to behavioral tests on preoperative day 1 and 7 after operation. Mechanical and thermal hypersensitivity in animals was determined by
measuring the mechanical withdrawal threshold (MWT) (a) and the thermal withdrawal latency (TWL) (b). #P < 0.05 vs. sham; *P < 0.05 vs. CCI
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HBO reversed Wnt-10 up-regulation induced by CCI
Considering that Wnt signaling lies downstream of
Kindlin-1 [17], we next investigated the expression of
Wnt-10a in the DRG, spinal cord, and hippocampal re-
gions of animals from different experimental groups.
The number of Wnt-10a-positive cells were dramatically
increased in the DRG and spinal cord obtained from
CCI rats (Fig. 5, P < 0.05 vs. sham), which was effectively
reversed by HBO therapy (P < 0.05 vs. CCI). Similarly,
Western blot analysis further demonstrated that Wnt-
10a protein expression was greatly up-regulated in the
DRG, spinal cord, and hippocampus of animals in the
CCI group (P < 0.05 vs. sham), whereas HBO treatment
significantly attenuated the elevation of Wnt-10a in
these neuronal tissues (P < 0.05 vs. CCI) (Fig. 6). These
observations suggest that HBO may reduce neuropathic
pain, possibly by regulating the Kindlin-1/Wnt-10a sig-
naling pathway in rat neuronal tissues.
Discussion
By establishing a rat neuropathic pain model, we were
able to investigate the effects of HBO on pain relief after
CCI of the sciatic nerve. Our results show that HBO
treatment efficiently suppressed mechanical and thermal
hypersensitivity in CCI rats. The antinociceptive effects
of HBO appear to be related to its action of suppressing
astrocyte activation and inflammatory responses via the
Kindlin-1/Wnt-10a inflammatory signaling pathway.
Fig. 2 Immunohistochemical analysis of the Kindlin-1 expression in the DRG, spinal cord and hippocampal tissues. a On postoperative day 7, tissues
were collected and underwent immunohistochemical analysis using an anti-Kindlin-1 antibody. Representative images are presented. b The average
OD for immunolabeling was calculated from four rats in each group. *P < 0.05
Fig. 3 Western blot analysis of Kindlin-1 expression in DRG, spinal cord and hippocampal tissue. a On postoperative day 7, tissues were collected
and underwent Western blot analysis. Representative images are presented. b Kindlin-1 protein expression of was standardized according to β-actin
levels. N = 4 for each group. *P < 0.05
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HBO treatment has been recognized as a promising
non-invasive therapy for a variety of disorders, includ-
ing neuropathic pain [9]. The antinociceptive efficacy
of HBO treatment has been proven in many rodent
experiments and also human patients [9–11, 13]. In
accordance with these findings, our current study
demonstrated that five consecutive days of HBO
treatment greatly attenuated neuropathic pain by sup-
pressing hypersensitivity in rats following CCI of the
sciatic nerve. Thermal hypersensitivity occurred earl-
ier than mechanical hypersensitivity in rats following
CCI, and HBO treatment effectively reduced both hy-
persensitivities. Based on previous studies and our
present findings, HBO therapy may be a novel non-
pharmacological approach for alleviating neuropathic
pain. However, the efficacy of long-term HBO treat-
ment has yet to be investigated.
Astrocytes, the most abundant cells in the central ner-
vous system, play an essential role in the induction of in-
flammation and neuropathic pain [20]. Compared with
other types of glial cells, such as microglia, significant
and persistent activation of astrocytes is a common fea-
ture following painful injury [21]. Pro-inflammatory
cytokines, such as TNF-α, released from activated astro-
cyte following injury, contribute to the development of
inflammation as well as neuropathic pain [22, 23]. Our
previous study showed that on postoperative day 7, there
was significant astrocyte activation in the spinal dorsal
horn in CCI rats [10], implying a crucial role of spinal
cord astrocytes in modulating neuroinflammation in
neuropathic pain conditions. In addition to the spinal
cord, the DRG participate in the regulation of neuroim-
mune responses in neuropathic pain, as demonstrated
by the differential expression of inflammatory neuropep-
tides and altered activation of peripheral immune cells
in this region after painful injury [24, 25]. The hippo-
campus, a key integration site for pain signals, regulates
CCI-induced pain behavior in rats [26]. Based on this
evidence, we focused on investigating astrocyte activa-
tion and related inflammatory mechanisms in the DRG,
spinal cord, and hippocampus of CCI-treated rats. Our
results demonstrated that astrocyte activation occurred
and was accompanied by elevated TNF-α levels in
central nervous system tissues following CCI. HBO
treatment efficiently prevented astrocyte activation and
production of TNF-α induced by CCI. Similar results
were obtained by other research groups, whereby HBO
therapy alleviated CCI-induced neuropathic pain as well
as reducing generation of pain [27]. These combined
data suggest that HBO therapy may suppress mechanical
and thermal hyperalgesia through inhibition of astrocyte
activation-evoked neuroinflammation.
A recent study reported that astrocyte activation in re-
sponse to mechanical and inflammatory stimuli was
linked to components of extracellular matrix (ECM)
[15]. Inhibition of ECM protein receptors by blockade of
β1 integrins suppressed astrocyte responses to ECM
components [15]. Kindlin-1 is an integrin binding pro-
tein [16], however its effects in astrocyte activation and
neuroinflammation in neuropathic pain have not yet
been studied. It is conceivable that CCI may induce
astrocyte activation through up-regulation of Kindlin-1.
A growing body of evidence also suggests that Wnt
Fig. 4 HBO suppresses astrocyte activation. On postoperative day 7,
sections of the DRG, spinal cord, and hippocampal tissues were stained
with anti-glial fibrillary acidic protein (GFAP) (green) antibody. Nuclei were
counterstained with DAPI. a Representative micrographs. b Quantification
of the percentage of GFAP-labeled astrocytes. c TNF-α generation was
examined by ELISA. N= 4 for each group. *P< 0.05
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family members play crucial roles in the pathogen-
esis of neuropathic pain. Neuronal injury leads to
the rapid and persistent activation of Wnt signals,
while blockade of the Wnt signaling pathway in-
hibits the development and progression of neuro-
pathic pain [28–30]. Moreover, Wnt, a downstream
effecter of Kindlin-1 [17], has been found to stimu-
late the release of pro-inflammatory cytokines, such
as TNF-α and IL-18, in models of neuropathic pain
[28]. In accordance with these observations, in-
creased Wnt-10a expression was detected in the
spinal cord, DRG, and hippocampus of CCI-treated
rats. Importantly, HBO therapy reversed the up-
regulation of Kindlin-1 as well as Wnt-10a caused
by CCI, suggesting the antinociceptive effects of
HBO treatment may result from Kindlin-1/Wnt
signaling-mediated suppression of astrocyte activa-
tion and inflammation.
Conclusions
The role of Kindlin-1/Wnt-10a in pain, astrocyte activation,
or neuroinflammation has not yet been clarified. Our
present study for the first time, demonstrated that HBO
treatment, likely via regulating the Kindlin-1/Wnt-10a sig-
naling pathway, attenuated rat neuropathic pain induced by
CCI of rat sciatic nerve. These data suggest that use of HBO
may be a novel therapeutic approach in alleviating neuro-
pathic pain in patients. Moreover, interference with the
Kindlin-1/Wnt-10a signaling pathway may also prove to be
a drug target for reducing neuroinflammatory responses of
astrocytes in the pathogenesis of neuropathic pain.
Fig. 5 Immunolabeling of Wnt-10a expression in DRG, spinal cord, and hippocampal tissues. a On postoperative day 7, tissue samples
were immunostained with anti-Wnt-10a antibody. Nuclei were counterstained with DAPI. Representative images were presented. b The
average number of Wnt-10a-positive cells was calculated from four rats in each group.*P < 0.05
Fig. 6 Western blot analysis of Wnt-10a expression in the DRG, spinal cord and hippocampal tissues. a On postoperative day 7, tissues were collected
and subjected to Western blot analysis. Representative images are presented. b Wnt-10a protein expression was standardized according to β-actin
levels. N = 4 for each group. *P < 0.05
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